NCT05303480View on ClinicalTrials.gov

Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

December 8, 2022

Study Completion Date

December 8, 2022

Conditions
Mycosis Fungoides
Interventions
DRUG

Chlormethine

Chlormethine gel 0.016%

Trial Locations (1)

2333 CL

Centre for Human Drug Research, Leiden

All Listed Sponsors
collaborator

Recordati Rare Diseases

INDUSTRY

lead

Centre for Human Drug Research, Netherlands

OTHER

NCT05303480 - Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides | Biotech Hunter | Biotech Hunter